IN-PERSON CONTACTS : BIOPHARMACEUTICALS & DIAGNOSTICS


JAPAN: TOP DOMESTIC COMPANIES (*merged of 2005-2007)

Takeda Dainippon Sumitomo* Ono Pharmaceutical
Astellas (Yamanouchi + Fujisawa)* Chugai (50.1% Roche) Kyowa Hakko
Daiichi Sankyo* Taisho Taiho
Eisai Shionogi Meiji Seika
Mitsubishi Tanabe* Otsuka Nippon Shinyaku


JAPAN: OTHER TRADITIONAL & NON-TRADITIONAL COMPANIES

Ajinomoto Nippon Kayaku
Asahi Chemical (merged Toyo Jozo) Nippon Zoki
Aska (Teikoku Hormone + Grelan)* Nissan Chemical
CMIC (#1 Japanese CRO) Nisshin Kyorin (former Nisshin Flour)
Eiken Chemical Olympus
Fujirebio (merged Special Reference Labs)* Santen
Fuso Pharmaceutical Sanwa Kagaku
Hisamitsu Pharmaceutical Seikagaku
Hitachi Chemical Senju Pharmaceutical
Japan Tobacco (merged Torii) Shiseido
Kaken SymBio
Kaketsuken (Chemo-Sera) Sysmex
Kao Takara Shuzo
Kirin Brewery Teijin
Kissei Pharmaceutical Teikoku Seiyaku
Kowa Company (merged Nikken Chemicals)* Terumo
Kyorin Pharmaceutical Toray
Maruho Toyama Chemical
Maruishi Tsumura
Mochida Yakult Honsha
Nihon Medi-Physics Zenyaku
Nippon Chemiphar Zeria

CHINA:

Direct, in-person contacts with Presidents in Shenzhen, Shanghai, Chongqing, and Beijing.

KOREA:

All of the 15 largest ethical drug companies and their President and/or head of Business Development and Licensing. Plus, the Korea Pharmaceutical Manufacturers Association and Korea Drug Research & Development Association.